Results
2301
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2301 companies
Astria Therapeutics
Market Cap: US$230.8m
A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for allergic and immunological diseases in the United States.
ATXS
US$4.37
7D
11.5%
1Y
-51.3%
MediWound
Market Cap: US$230.4m
A biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States and internationally.
MDWD
US$21.08
7D
6.0%
1Y
31.7%
Optima Health
Market Cap: UK£170.5m
Provides occupational health and wellbeing services for the public and private sectors in the United Kingdom.
OPT
UK£1.92
7D
0.3%
1Y
n/a
Nuvectis Pharma
Market Cap: US$228.3m
A clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology.
NVCT
US$9.66
7D
-3.9%
1Y
50.5%
Cartesian Therapeutics
Market Cap: US$227.6m
A clinical-stage biotechnology company, provides mRNA cell therapies for the treatment of autoimmune diseases.
RNAC
US$9.09
7D
-2.0%
1Y
-68.7%
Tactile Systems Technology
Market Cap: US$227.1m
A medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States.
TCMD
US$9.84
7D
-0.1%
1Y
-23.3%
Foghorn Therapeutics
Market Cap: US$225.8m
A clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system in the United States.
FHTX
US$4.30
7D
5.9%
1Y
-23.6%
Fennec Pharmaceuticals
Market Cap: US$224.5m
Operates as a commercial stage biopharmaceutical company in the United States.
FENC
US$8.12
7D
-2.1%
1Y
13.6%
Tango Therapeutics
Market Cap: US$222.2m
A precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need.
TNGX
US$1.94
7D
2.6%
1Y
-71.3%
Design Therapeutics
Market Cap: US$220.3m
A clinical-stage biopharmaceutical company, research, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States.
DSGN
US$4.00
7D
11.1%
1Y
3.9%
Performant Healthcare
Market Cap: US$220.0m
Provides audit, recovery, and analytics services in the United States.
PHLT
US$2.81
7D
7.7%
1Y
-8.2%
Dimerix
Market Cap: AU$340.6m
A biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia.
DXB
AU$0.57
7D
-2.6%
1Y
25.3%
Medical Facilities
Market Cap: CA$302.1m
Through its subsidiaries, owns and operates specialty surgical hospitals and ambulatory surgery center in the United States.
DR
CA$15.88
7D
3.1%
1Y
34.6%
Annexon
Market Cap: US$216.1m
A clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases.
ANNX
US$2.03
7D
3.0%
1Y
-56.8%
Monopar Therapeutics
Market Cap: US$215.5m
A clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States.
MNPR
US$32.46
7D
-8.7%
1Y
947.1%
ProKidney
Market Cap: US$213.7m
A clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States.
PROK
US$0.71
7D
-8.5%
1Y
-82.2%
Aardvark Therapeutics
Market Cap: US$213.1m
A clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases.
AARD
US$10.21
7D
-8.2%
1Y
n/a
Codexis
Market Cap: US$211.3m
Provides enzymatic solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, and enhance novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China.
CDXS
US$2.33
7D
-0.4%
1Y
-27.0%
Integrated Diagnostics Holdings
Market Cap: US$209.3m
Operates as a consumer healthcare company that provides medical diagnostics services to patients.
IDHC
US$0.36
7D
0%
1Y
14.3%
Bioventix
Market Cap: UK£154.1m
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.
BVXP
UK£29.50
7D
3.5%
1Y
-31.4%
OraSure Technologies
Market Cap: US$207.2m
Develops, manufactures, markets, sells, and distributes diagnostic products, specimen collection devices, and other diagnostic products in the United States, Europe, Africa, and internationally.
OSUR
US$2.77
7D
8.8%
1Y
-40.8%
VitaSpring Biomedical
Market Cap: US$207.0m
Focuses on the development of drugs of cell medicine.
VSBC
US$1.00
7D
0%
1Y
n/a
Cardiff Oncology
Market Cap: US$206.2m
A clinical-stage biotechnology company, develops novel therapies for the treatment of various cancers.
CRDF
US$3.19
7D
10.0%
1Y
-0.3%
enGene Holdings
Market Cap: US$203.9m
Through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines to help patients suffering from bladder cancer.
ENGN
US$3.99
7D
-1.2%
1Y
-68.7%
Actuate Therapeutics
Market Cap: US$202.3m
A clinical-stage biopharmaceutical company, develops therapies for the treatment of cancers in the United States.
ACTU
US$10.79
7D
-1.7%
1Y
n/a
Bright Minds Biosciences
Market Cap: CA$278.1m
A biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States.
DRUG
CA$38.04
7D
-14.5%
1Y
2,037.1%
biote
Market Cap: US$200.0m
Operates in practice-building business within the hormone optimization space.
BTMD
US$3.53
7D
-8.8%
1Y
-47.5%
Y-mAbs Therapeutics
Market Cap: US$199.7m
A commercial-stage biopharmaceutical company, focuses on the development and commercialization of radioimmunotherapy and antibody based therapeutic products for the treatment of cancer.
YMAB
US$4.62
7D
12.7%
1Y
-62.3%
Quanterix
Market Cap: US$197.4m
A life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions.
QTRX
US$5.28
7D
9.8%
1Y
-67.4%
SOPHiA GENETICS
Market Cap: US$193.8m
Operates as a cloud-native software technology company in the healthcare space.
SOPH
US$2.87
7D
-2.0%
1Y
-44.2%
ME Therapeutics Holdings
Market Cap: CA$267.1m
A preclinical stage biotechnology company, engages in the development of cancer fighting drugs in the field of immuno-oncology.
METX
CA$10.26
7D
0%
1Y
157.1%
BioStem Technologies
Market Cap: US$191.4m
A life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services.
BSEM
US$11.65
7D
-0.9%
1Y
38.5%
4basebio
Market Cap: UK£142.1m
Engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and targeted non-viral vector solutions in the United States, Europe, and internationally.
4BB
UK£11.10
7D
-1.3%
1Y
-21.0%
CARGO Therapeutics
Market Cap: US$191.4m
A clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients.
CRGX
US$4.13
7D
1.7%
1Y
-77.1%
Monash IVF Group
Market Cap: AU$296.1m
Provides assisted reproductive and specialist women imaging services in Australia and Malaysia.
MVF
AU$0.77
7D
-1.9%
1Y
-45.8%
Inhibrx Biosciences
Market Cap: US$190.1m
A clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions.
INBX
US$12.91
7D
-1.9%
1Y
-7.3%